They are the ones to read carefully
Exenatide, MedlinePlus (2021) Dulaglutide, MedlinePlus (2023) Obesity in adolescents, The New England Journal of Medicine (2023) Nutrition and pubertal development, Indian Journal of Endocrinology and Metabolism (2014) GLP-1 receptor agonists and eating disorders, National Eating Disorder Association (n.d.) Facts about falls, Centers for Disease Control and Prevention (2024) Hypoglycemia in older people a less well recognized risk factor for frailty, Aging and Disease (2015) Ozempic, Novo Nordisk Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
This test helps identify your genetic predisposition to GLP-1 pathway responsiveness, allowing PlexusDx providers to optimize your treatment protocol before titrating your dose
Lets be direct about what this means for consumers: nobody, not HIMS, not the compounding pharmacy, not the prescribing provider, has any idea what the actual plasma concentration of semaglutide is after a patient takes this pill